News

Revolutionizing Clinical Trials with Automation and AI Tools

Revolutionizing Clinical Trials with Automation and AI Tools

Transforming Clinical Trials with Innovative Automation

Research Grid has unveiled a groundbreaking Site Feasibility solution designed to drastically streamline the process of launching clinical trials. With this new initiative, the timeline for site feasibility evaluations, which previously spanned six months, is now reduced to mere minutes. This significant advancement not only accelerates trial startups but also expands access to diverse patient populations globally.

The Need for Change in Clinical Research

The clinical research landscape faces numerous challenges, particularly in the area of site feasibility. Historically, trial sponsors and Contract Research Organizations (CROs) encountered several obstacles due to manual processes, outdated data, and inconsistent outreach efforts. Research Grid recognized that feasibility assessments were often the bottlenecks in clinical trials, leading to extended timelines and costly delays.

Understanding the Bottlenecks

Several statistics illustrate the extent of the challenges faced by clinical trials. A staggering 80% of trials do not meet enrollment deadlines, with over 30% of sites failing to enroll enough participants. The consequences of these issues extend beyond mere inconvenience; 85% of studies incur additional costs due to recruitment delays, and site personnel can spend thousands of hours each year navigating feasibility processes.

Introducing Research Grid’s Solution

The newly launched Site Feasibility solution by Research Grid utilizes real-world data combined with an expansive network of over 97,000 communities, covering diverse regions and medical indications. This technological advancement propels sponsors and CROs to easily identify the most suitable trial sites, assess their viability quickly, and initiate the studies without unnecessary delays.

Key Features of the Site Feasibility Tool

Research Grid’s Site Feasibility tool is engineered to deliver instant insights linked to specific protocols. Here are some of the standout features:

  • Global Patient Reach: Gain access to a carefully curated network of over 96,000 verified communities across 157 countries, aligned with diverse protocol requirements.
  • Accelerated Planning: Replace traditional outreach efforts of several weeks with instant feasibility reports boosted by AI technology.
  • Equity-Focused Design: This tool prioritizes inclusivity by facilitating the identification of underrepresented regions, ensuring diverse and equitable enrollment in clinical trials.
  • Enhanced Recruitment Strategies: Focus on sites demonstrating real patient access rather than historical performance metrics alone.
  • Streamlined Workflow: Manage and track feasibility processes effectively across global teams within a single platform.

Available now, the tool can be used in a self-service capacity or through a fully managed service, providing a flexible approach to feasibility assessments for both individual trials and broader portfolios.

A Commitment to Innovation

This launch aligns with Research Grid's mission to replace outdated, manual processes with intelligent automation. The impact of this technology extends beyond mere efficiency; it supports more inclusive and equitable access to clinical trials, ensuring that critical medical advancements can reach patients in need more swiftly.

About Research Grid

Founded in 2020 by Dr. Amber Hill, Research Grid serves as the backbone of modern clinical trials. By addressing historic inefficiencies caused by legacy systems, the company enables faster and more successful trials through smart software solutions. With a total of $8 million raised in venture funding, Research Grid is headquartered in London, dedicated to providing innovative tools for patient and community engagement as well as comprehensive clinical trial management.

Frequently Asked Questions

What is Research Grid's new Site Feasibility solution?

It's a tool designed to significantly reduce the time taken for site feasibility assessments from six months to mere minutes.

How does the tool enhance recruitment for clinical trials?

It focuses on sites that demonstrate real patient access and uses real-world data to optimize the recruitment process.

Why is feasibility an important aspect of clinical trials?

Feasibility affects trial timelines and costs; bottlenecks can lead to missed deadlines and increased expenses.

What industries can benefit from Research Grid's solutions?

Clinical research, particularly in pharmaceutical and biotechnology sectors, can significantly benefit from the automation and efficiency provided by Research Grid.

What is the vision of Research Grid?

The company's mission is to enhance clinical trials' success rates by leveraging smart software tools that automate tedious back-office tasks.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 3

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 1

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 2

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 2

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 1

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 1

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 7

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading

Top 5 Most Recently Viewed Articles

Stämm and SuperMeat Join Forces to Innovate Cultivated Meat

Updated Category News Views 152

Revolutionizing Cultivated Meat Production through Collaboration Stämm has recently announced an exciting collaboration with SuperMeat to accelerate developments in cultivated meat biomanufacturing. With Varana Capital's strategic backing, this partnership seeks to enhance SuperMeat's cultivated chicken production process using Stämm's innovative bioreactor...

Continue Reading
Manchester United Reports Declining Fourth Quarter Earnings

Updated Category News Views 124

Manchester United Reports Its Fourth Quarter Results Manchester United PLC (NYSE: MANU) has recently released its fiscal fourth-quarter results for 2024. The numbers show a significant year-on-year sales drop of 15.0%, totaling 142.2 million British pounds, or about $179.43 million. Unfortunately, this result didn't meet analysts' expectations, which had projected sales...

Continue Reading
China's Rural Road Achievements Fuel Sustainable Development

Updated Category News Views 273

China's Rural Road Achievements and Future Vision Recently, the State Council Information Office of China unveiled an insightful white paper titled "China's Rural Roads in the New Era." This document highlights the incredible accomplishments and future aspirations concerning rural road development in the country. The white paper reveals that by the end of 2023, China's...

Continue Reading
Tyson Foods Released Impressive Fourth Quarter Earnings

Updated Category News Views 148

Overview of Fourth Quarter Results Tyson Foods, Inc. (NYSE: TSN), recognized as one of the largest food companies in the world, has showcased impressive financial performance for the fourth quarter of 2025. The company reported sales of $13,860 million, marking a 2.2% increase compared to the corresponding quarter in the previous year. When excluding legal contingency...

Continue Reading
Good Cheer Triumphs at the Renowned Longines Kentucky Oaks

Updated Category News Views 362

Good Cheer Captures the Victory in Kentucky Oaks Excitement filled the air as Good Cheer claimed a notable victory in the Longines Kentucky Oaks, a highlight of the horse racing calendar. This remarkable race saw Good Cheer emerge victorious in a challenging environment with sloppy track conditions, competing against a strong field of 13 fillies. Record-Worthy Wagering at...

Continue Reading